Lv2
140 积分 2026-09-15 加入
参麦兰苓汤辅助利拉鲁肽治疗2型糖尿病合并非酒精性脂肪肝的效果观察
1个月前
已完结
The glucagon and GLP-1 receptor dual agonist DD01 for metabolic dysfunction-associated steatotic liver disease and steatohepatitis (DD01-DN-02): 12-week results from a randomised, double-blind, multicentre, placebo-controlled, phase 2 trial
1个月前
已完结
The glucagon and GLP-1 receptor dual agonist DD01 for metabolic dysfunction–associated steatotic liver disease and steatohepatitis (DD01-DN-02): 12-week results from a randomised, double-blind, multicentre, placebo-controlled, phase 2 trial
1个月前
已关闭
皖公网安备34019202002308
